Author Archives: Thomas Payne

TScan Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Progress

By

TScan Therapeutics to Participate in the 13th Annual Wedbush PacGrow Healthcare Conference

By

TScan Therapeutics Announces Publication in Cell Highlighting the Discovery of Tumor Antigens and TCRs for the Treatment of Solid Tumors Using Foundational Screening Technology

By

TScan Therapeutics Appoints Debora Barton, M.D., as Chief Medical Officer

By

TScan Therapeutics to Participate in the LifeSci 2nd Annual Genetic Medicines Symposium

By

TScan Therapeutics to Participate in the 2022 Jefferies Healthcare Conference

By

TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-101 for the Treatment of Hematologic Malignancies

By

TScan Therapeutics Presents Preclinical Data at the American Society of Gene and Cell Therapy 25th Annual Meeting

By

TScan Therapeutics to Participate in the H.C. Wainwright Global Investment Conference

By

TScan Therapeutics to Host Virtual KOL Event to Discuss its Solid Tumor Program Strategy and Highlights from the ASGCT 25th Annual Meeting

By